eF-site ID 4zx3-A
PDB Code 4zx3
Chain A

click to enlarge
Title X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10b
Classification HYDROLASE/HYDROLASE INHIBITOR
Compound M1 family aminopeptidase
Source (AMP1_PLAFQ)
Sequence A:  PKIHYRKDYKPSGFIINQVTLNINIHDQETIVRSVLDMDI
SKHNVGEDLVFDGVGLKINEISINNKKLVEGEEYTYDNEF
LTIFSKFVPKSKFAFSSEVIIHPETNYALTGLYKSKNIIV
SQCEATGFRRITFFIDRPDMMAKYDVTVTADKEKYPVLLS
NGDKVNEFEIPGGRHGARFNDPPLKPCYLFAVVAGDLKHL
SATYITKYTKKKVELYVFSEEKYVSKLQWALECLKKSMAF
DEDYFGLEYDLSRLNLVAVSDFNVGAMENKGLNIFNANSL
LASKKNSIDFSYARILTVVGHEYFHQYTGNRVTLRDWFQL
TLKEGLTVHRENLFSEEMTKTVTTRLSHVDLLRSVQFLED
SSPLSHPIRPESYVSMENFYTTTVYDKGSEVMRMYLTILG
EEYYKKGFDIYIKKNDGNTATCEDFNYAMEQAYKMKKADN
SANLNQYLLWFSQSGTPHVSFKYNYDAEKKQYSIHVNQYT
KPDENQKEKKPLFIPISVGLINPENGKEMISQTTLELTKE
SDTFVFNNIAVKPIPSLFRGFSAPVYIEDQLTDEERILLL
KYDSDAFVRYNSCTNIYMKQILMNYNEFLKAKNEKLESFQ
LTPVNAQFIDAIKYLLEDPHADAGFKSYIVSLPQDRYIIN
FVSNLDTDVLADTKEYIYKQIGDKLNDVYYKMFKSLEAKA
DDLTYFNDESHVDFDQMNMRTLRNTLLSLLSKAQYPNILN
EIIEHSKSPYPSNWLTSLSVSAYFDKYFELYDKTYKLSKD
DELLLQEWLKTVSRSDRKDIYEILKKLENEVLKDSKNPND
IRAVYLPFTNNLRRFHDISGKGYKLIAEVITKTDKFNPMV
ATQLCEPFKLWNKLDTKRQELMLNEMNTMLQEPQISNNLK
EYLLRLTNK
Description


Functional site

1) chain A
residue 496
type
sequence H
description binding site for residue ZN A 1101
source : AC1

2) chain A
residue 500
type
sequence H
description binding site for residue ZN A 1101
source : AC1

3) chain A
residue 519
type
sequence E
description binding site for residue ZN A 1101
source : AC1

4) chain A
residue 459
type
sequence V
description binding site for residue 4TK A 1102
source : AC2

5) chain A
residue 460
type
sequence G
description binding site for residue 4TK A 1102
source : AC2

6) chain A
residue 461
type
sequence A
description binding site for residue 4TK A 1102
source : AC2

7) chain A
residue 463
type
sequence E
description binding site for residue 4TK A 1102
source : AC2

8) chain A
residue 489
type
sequence R
description binding site for residue 4TK A 1102
source : AC2

9) chain A
residue 496
type
sequence H
description binding site for residue 4TK A 1102
source : AC2

10) chain A
residue 497
type
sequence E
description binding site for residue 4TK A 1102
source : AC2

11) chain A
residue 500
type
sequence H
description binding site for residue 4TK A 1102
source : AC2

12) chain A
residue 519
type
sequence E
description binding site for residue 4TK A 1102
source : AC2

13) chain A
residue 575
type
sequence Y
description binding site for residue 4TK A 1102
source : AC2

14) chain A
residue 580
type
sequence Y
description binding site for residue 4TK A 1102
source : AC2

15) chain A
residue 250
type
sequence G
description binding site for residue MG A 1103
source : AC3

16) chain A
residue 572
type
sequence E
description binding site for residue DMS A 1105
source : AC5

17) chain A
residue 573
type
sequence N
description binding site for residue DMS A 1105
source : AC5

18) chain A
residue 575
type
sequence Y
description binding site for residue DMS A 1105
source : AC5

19) chain A
residue 759
type
sequence S
description binding site for residue DMS A 1106
source : AC6

20) chain A
residue 761
type
sequence A
description binding site for residue DMS A 1106
source : AC6

21) chain A
residue 764
type
sequence R
description binding site for residue DMS A 1106
source : AC6

22) chain A
residue 496
type BINDING
sequence H
description BINDING => ECO:0000269|PubMed:19196988, ECO:0000269|PubMed:21366301, ECO:0000269|PubMed:21844374, ECO:0000269|PubMed:23713488, ECO:0000269|PubMed:23897806, ECO:0000269|PubMed:25299353, ECO:0000269|PubMed:25645579, ECO:0000269|PubMed:26406322, ECO:0000269|PubMed:26807544, ECO:0000269|PubMed:30537832, ECO:0000269|PubMed:32182520, ECO:0000269|Ref.21, ECO:0000269|DOI:10.1016/j.cclet.2021.09.102, ECO:0000312|PDB:3T8V, ECO:0000312|PDB:5Y1Q, ECO:0007744|PDB:3EBG, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43, ECO:0007744|PDB:3Q44, ECO:0007744|PDB:4J3B, ECO:0007744|PDB:4K5L, ECO:0007744|PDB:4K5M, ECO:0007744|PDB:4K5N, ECO:0007744|PDB:4K5O, ECO:0007744|PDB:4K5P, ECO:0007744|PDB:4R5T, ECO:0007744|PDB:4R5V, ECO:0007744|PDB:4R5X, ECO:0007744|PDB:4X2U, ECO:0007744|PDB:4ZQT, ECO:0007744|PDB:4ZW3, ECO:0007744|PDB:4ZW5, ECO:0007744|PDB:4ZW6, ECO:0007744|PDB:4ZW7, ECO:0007744|PDB:4ZW8, ECO:0007744|PDB:4ZX3, ECO:0007744|PDB:4ZX4, ECO:0007744|PDB:4ZX5, ECO:0007744|PDB:4ZX6, ECO:0007744|PDB:5XM7, ECO:0007744|PDB:5Y19, ECO:0007744|PDB:5Y1H, ECO:0007744|PDB:5Y1K, ECO:0007744|PDB:5Y1R, ECO:0007744|PDB:5Y1S, ECO:0007744|PDB:5Y1T, ECO:0007744|PDB:5Y1V, ECO:0007744|PDB:5Y1W, ECO:0007744|PDB:5Y1X, ECO:0007744|PDB:5Y3I, ECO:0007744|PDB:6EA1, ECO:0007744|PDB:6EA2, ECO:0007744|PDB:6EAA, ECO:0007744|PDB:6EAB, ECO:0007744|PDB:6EE3, ECO:0007744|PDB:6EE4, ECO:0007744|PDB:6EE6, ECO:0007744|PDB:6EED, ECO:0007744|PDB:6SBQ, ECO:0007744|PDB:6SBR
source Swiss-Prot : SWS_FT_FI4

23) chain A
residue 500
type BINDING
sequence H
description BINDING => ECO:0000269|PubMed:19196988, ECO:0000269|PubMed:21366301, ECO:0000269|PubMed:21844374, ECO:0000269|PubMed:23713488, ECO:0000269|PubMed:23897806, ECO:0000269|PubMed:25299353, ECO:0000269|PubMed:25645579, ECO:0000269|PubMed:26406322, ECO:0000269|PubMed:26807544, ECO:0000269|PubMed:30537832, ECO:0000269|PubMed:32182520, ECO:0000269|Ref.21, ECO:0000269|DOI:10.1016/j.cclet.2021.09.102, ECO:0000312|PDB:3T8V, ECO:0000312|PDB:5Y1Q, ECO:0007744|PDB:3EBG, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43, ECO:0007744|PDB:3Q44, ECO:0007744|PDB:4J3B, ECO:0007744|PDB:4K5L, ECO:0007744|PDB:4K5M, ECO:0007744|PDB:4K5N, ECO:0007744|PDB:4K5O, ECO:0007744|PDB:4K5P, ECO:0007744|PDB:4R5T, ECO:0007744|PDB:4R5V, ECO:0007744|PDB:4R5X, ECO:0007744|PDB:4X2U, ECO:0007744|PDB:4ZQT, ECO:0007744|PDB:4ZW3, ECO:0007744|PDB:4ZW5, ECO:0007744|PDB:4ZW6, ECO:0007744|PDB:4ZW7, ECO:0007744|PDB:4ZW8, ECO:0007744|PDB:4ZX3, ECO:0007744|PDB:4ZX4, ECO:0007744|PDB:4ZX5, ECO:0007744|PDB:4ZX6, ECO:0007744|PDB:5XM7, ECO:0007744|PDB:5Y19, ECO:0007744|PDB:5Y1H, ECO:0007744|PDB:5Y1K, ECO:0007744|PDB:5Y1R, ECO:0007744|PDB:5Y1S, ECO:0007744|PDB:5Y1T, ECO:0007744|PDB:5Y1V, ECO:0007744|PDB:5Y1W, ECO:0007744|PDB:5Y1X, ECO:0007744|PDB:5Y3I, ECO:0007744|PDB:6EA1, ECO:0007744|PDB:6EA2, ECO:0007744|PDB:6EAA, ECO:0007744|PDB:6EAB, ECO:0007744|PDB:6EE3, ECO:0007744|PDB:6EE4, ECO:0007744|PDB:6EE6, ECO:0007744|PDB:6EED, ECO:0007744|PDB:6SBQ, ECO:0007744|PDB:6SBR
source Swiss-Prot : SWS_FT_FI4

24) chain A
residue 519
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:19196988, ECO:0000269|PubMed:21366301, ECO:0000269|PubMed:21844374, ECO:0000269|PubMed:23713488, ECO:0000269|PubMed:23897806, ECO:0000269|PubMed:25299353, ECO:0000269|PubMed:25645579, ECO:0000269|PubMed:26406322, ECO:0000269|PubMed:26807544, ECO:0000269|PubMed:30537832, ECO:0000269|PubMed:32182520, ECO:0000269|Ref.21, ECO:0000269|DOI:10.1016/j.cclet.2021.09.102, ECO:0000312|PDB:3T8V, ECO:0000312|PDB:5Y1Q, ECO:0007744|PDB:3EBG, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43, ECO:0007744|PDB:3Q44, ECO:0007744|PDB:4J3B, ECO:0007744|PDB:4K5L, ECO:0007744|PDB:4K5M, ECO:0007744|PDB:4K5N, ECO:0007744|PDB:4K5O, ECO:0007744|PDB:4K5P, ECO:0007744|PDB:4R5T, ECO:0007744|PDB:4R5V, ECO:0007744|PDB:4R5X, ECO:0007744|PDB:4X2U, ECO:0007744|PDB:4ZQT, ECO:0007744|PDB:4ZW3, ECO:0007744|PDB:4ZW5, ECO:0007744|PDB:4ZW6, ECO:0007744|PDB:4ZW7, ECO:0007744|PDB:4ZW8, ECO:0007744|PDB:4ZX3, ECO:0007744|PDB:4ZX4, ECO:0007744|PDB:4ZX5, ECO:0007744|PDB:4ZX6, ECO:0007744|PDB:5XM7, ECO:0007744|PDB:5Y19, ECO:0007744|PDB:5Y1H, ECO:0007744|PDB:5Y1K, ECO:0007744|PDB:5Y1R, ECO:0007744|PDB:5Y1S, ECO:0007744|PDB:5Y1T, ECO:0007744|PDB:5Y1V, ECO:0007744|PDB:5Y1W, ECO:0007744|PDB:5Y1X, ECO:0007744|PDB:5Y3I, ECO:0007744|PDB:6EA1, ECO:0007744|PDB:6EA2, ECO:0007744|PDB:6EAA, ECO:0007744|PDB:6EAB, ECO:0007744|PDB:6EE3, ECO:0007744|PDB:6EE4, ECO:0007744|PDB:6EE6, ECO:0007744|PDB:6EED, ECO:0007744|PDB:6SBQ, ECO:0007744|PDB:6SBR
source Swiss-Prot : SWS_FT_FI4

25) chain A
residue 459
type SITE
sequence V
description Important for substrate specificity => ECO:0000269|PubMed:23897806
source Swiss-Prot : SWS_FT_FI5

26) chain A
residue 580
type SITE
sequence Y
description Transition state stabilizer => ECO:0000250|UniProtKB:P15144
source Swiss-Prot : SWS_FT_FI6

27) chain A
residue 795
type SITE
sequence Q
description Cleavage => ECO:0000305|PubMed:21659511
source Swiss-Prot : SWS_FT_FI7

28) chain A
residue 497
type ACT_SITE
sequence E
description Proton acceptor => ECO:0000250|UniProtKB:P15144
source Swiss-Prot : SWS_FT_FI1

29) chain A
residue 493-502
type prosite
sequence VVGHEYFHQY
description ZINC_PROTEASE Neutral zinc metallopeptidases, zinc-binding region signature. VVGHEYFHQY
source prosite : PS00142

30) chain A
residue 463
type BINDING
sequence E
description BINDING => ECO:0000305|PubMed:19196988, ECO:0000305|PubMed:21366301, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43
source Swiss-Prot : SWS_FT_FI2

31) chain A
residue 319
type BINDING
sequence E
description BINDING => ECO:0000305|PubMed:19196988, ECO:0000305|PubMed:21366301, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43
source Swiss-Prot : SWS_FT_FI2

32) chain A
residue 460
type BINDING
sequence G
description BINDING => ECO:0000305|PubMed:19196988, ECO:0000305|PubMed:21366301, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3EBI, ECO:0007744|PDB:3Q43
source Swiss-Prot : SWS_FT_FI2

33) chain A
residue 461
type BINDING
sequence A
description BINDING => ECO:0000305|PubMed:19196988, ECO:0000305|PubMed:21366301, ECO:0007744|PDB:3EBH, ECO:0007744|PDB:3Q43
source Swiss-Prot : SWS_FT_FI3


Display surface

Download
Links